Zydus Cadila is going to present the data of its EVIDENCES IV clinical trial of Saroglitazar Magnesium, at The Liver Meeting 2019, the annual meeting of the American Association for the Study of Liver Diseases (AASLD), being held in Boston, Massachusetts, USA from November 8-12,, 2019.
Earlier Zydus had reported that the EVIDENCES IV clinical trial had achieved the primary end-points in patients with NAFLD and NASH.
Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.
